PHGE - BiomX Inc.
Close
0.7081
0 0%
Share volume: 200
Last Updated: Wed 08 Jan 2025 04:43:36 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$0.71
0.00
0.00%
View ratios
Fiscal Date | 2024-09-30 | |
---|---|---|
Fiscal Quarter | Q3 2024 | |
Report Date | 2024-11-14 | |
Total revenue | 20.643 M | |
Cost of revenue | 0.000 | |
Gross profit | 0.000 | |
Operating expenses | 0.000 | |
Selling general and admin | 0.000 | |
Research and development | 0.000 | |
Total expenses | 0.000 | |
Operating income | 0.000 | |
Ebit | 9.310 M | |
Pretax income | 9.642 M | |
Income tax | 0.000 | |
Net income basic | 0.000 | |
Net income | 9.642 M | |